Determination method of CYP3A activity and individualization dosage regimen of etoposide

ZHANG Shun-guo,ZHANG Jian,CHEN Min-ling
DOI: https://doi.org/10.3969/j.issn.1009-2501.2005.10.015
2005-01-01
Abstract:AIM: To explore the correlation between drug concentration of etoposide (VP16) and CYP3A activity (CA) in leukemia. METHODS: The urinary 6β-hydroxycortisol/hydrocortisone ratio is a useful marker for CA. Concentration of VP16 in plasma and CA was determined by HPLC in 20 leucemia patients, and the correlation analysis was performed using the SPSS software. RESULTS: Correlation analysis between drug concentration of VP16 and CA in leukemia was poor correlated (r = 0.725), but concentration of VP16 and lgCA showed a good correlated (r =0.969). CONCLUSION: It is feasible to adjust the therapeutic regimen of VP16 by determining CA.
What problem does this paper attempt to address?